NCT04114162

Brief Summary

Fluid management in septic shock patients remain a great challenge. Insufficient fluid filling lead to hypovolemia, organ failure and increased death, whereas fluid overload was associated to an increased morbidity and mortality in several studies. Several invasive and non invasive strategies have been developed during the past years to monitor the hemodynamic state of septic shock patients, but no method has been validated to objectively quantify fluid overload in septic shock patients. The Body Composition Monitor (BCM) allow for measurement of total body water (TBW), extracellular water (ECW) and intracellular water (ICW) volumes using bioimpedancemetry. The BCW is daily used in patients who undergo renal dialysis to assess the effectiveness of fluid removal. The BCM has never been validated in septic shock patients. The aim of the study is to investigate the accuracy of the BCM to measure the variation of the TBW during a fluid challenge of 500 ml of saline during the early phase of septic shock.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
64

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jan 2020

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 1, 2019

Completed
2 days until next milestone

First Posted

Study publicly available on registry

October 3, 2019

Completed
3 months until next milestone

Study Start

First participant enrolled

January 1, 2020

Completed
4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2023

Completed
1 day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2023

Completed
Last Updated

April 23, 2025

Status Verified

January 1, 2025

Enrollment Period

4 years

First QC Date

October 1, 2019

Last Update Submit

April 18, 2025

Conditions

Keywords

ICUSeptic shockFluid overloadQuantificationBioimpedancemetryCapillary leakFluid responsiveness

Outcome Measures

Primary Outcomes (1)

  • To assess the accuracy of the BCM to measure the variation of the TBW volume during a fluid challenge.

    The variation of the TBW volume measured by the BCM will be compared to the variation of the volume of fluids (fluid input minus fluid output) during a fluid challenge of 500 ml of saline. Fluid input will be the sum of the volume of all fluids and drugs delivered during the fluid challenge (including enteral nutrition). Fluid output will be the sum of all loss of fluid (surgical drain, urine output) during the fluid challenge.

    10 minutes

Secondary Outcomes (11)

  • To describe the variation of the ECW volume measured by the BCM during a fluid challenge of 500 ml of saline.

    10 minutes

  • To describe the variation of the ECW volume on TBW volume ratio during a fluid challenge of 500 ml of saline.

    10 minutes

  • To compare the phase angle value measured at T0 by the BCM between responders and non responders at T1.

    10 minutes

  • To describe the relationship between the phase angle value measured at T0 by the BCM and the capillary leak index.

    10 minutes

  • To compare the ECW/TBW ratio at T0 between responders and non responders at T1.

    10 minutes

  • +6 more secondary outcomes

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

ICU patient requiring fluid resuscitation for septic shock

You may qualify if:

  • Patient aged from 18 to 80 years old
  • Admitted to ICU for septic shock for less than 24 h
  • Fluid resuscitation decided by intensivist
  • Patient affiliated to a social security system or recipient of a such system
  • Patient/proxy not opposed to the study

You may not qualify if:

  • Subject with amputation of 1 or more limbs
  • Body mass index \> 35 kg.m-2 ou \< 18 kg.m-2
  • Impossibility of setting up an arterial catheter for invasive blood pressure monitoring and / or a central venous catheter in the upper cava territory
  • Patient with pacemaker and / or implantable cardioverter defibrillator
  • Quality of cardio echo image insufficient to allow studied parameters measurement
  • Moribund subject ( life expectancy expected less than 48 hours)
  • Uncontrolled intracranial hypertension (intracranial pressure ≥ 20 mm Hg by ICP monitoring or by a pulsatility index ≥ 1.30 in the transcranial Doppler)
  • Patient under ECMO/ECLS
  • Legal incapacity or limited legal capacity
  • Subject without health insurance
  • Pregnant woman

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Centre Hospitalier Universitaire de Besançon

Besançon, 25030, France

Location

MeSH Terms

Conditions

Shock, SepticEdema

Condition Hierarchy (Ancestors)

SepsisInfectionsSystemic Inflammatory Response SyndromeInflammationPathologic ProcessesPathological Conditions, Signs and SymptomsShockSigns and Symptoms

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 1, 2019

First Posted

October 3, 2019

Study Start

January 1, 2020

Primary Completion

December 30, 2023

Study Completion

December 31, 2023

Last Updated

April 23, 2025

Record last verified: 2025-01

Locations